glp-1 obesity drug news today october 2025 WHO Decision Recognizing as a Disease Treatable with Drugs Is “Big Deal,” says BU Endocrinologist | BU glp-1 obesity drug news october

What was found: Nitrate-reducing bacteria were killed by the addition of vitamin C in vitro

Your path to significant weight loss with cagrilintide requires commitment to proper titration, managing side effects proactively, maintaining adequate protein and hydration, supporting with diet and exercise, and understanding this is a long-term approach requiring 12-18+ months for maximum results and ongoing maintenance to prevent regain

These factors can lead to low B12 levels, causing symptoms such as fatigue, memory problems, and neuropathy (tingling in the hands and feet)

Towards optimal pH of the skin and topical formulations: From the current state of the art to tailored products

Staying at each dose level for 6 weeks instead of 4 reduces side effects for sensitive individuals